- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03123315
Optimization of Ureterolysis During Hysterectomy
February 24, 2018 updated by: Case Comprehensive Cancer Center
Optimization of Parameters for Ureterolysis During Minimally Invasive Hysterectomy; Determining Variation in Ureter Position and Degree of Thermal Spread
The purpose of this study is to improve the safety of surgery to remove a uterus (a hysterectomy) by better understanding where a patient's ureters lie.
Study Overview
Status
Withdrawn
Conditions
Intervention / Treatment
Detailed Description
Objectives:
Primary: (While uterus is under tension)
- To determine the shortest distance from the ureter to the uterine vessels.
- To determine the distances from the ureter to the gonadal vessels in infundibulo-pelvic (IP) at the pelvic sidewall. This will be defined at the distance from the IP ligament at the level of the pelvic sidewall to the point on the ureter directly below these vessels
- To determine the distances from the ureter to the gonadal vessels in the infundibulo-pelvic (IP) ligament at the point where the gonadal vessels enter in to the ovary. This will be defined as the distance from where the vessels in the IP enter the ovary to the point on the ureter directly below this.
Secondary
- To determine thermal spread from the Ligasure, and Harmonic device using H&E and Movat staining.
- To determine the burst pressure of segments of IP ligament that have undergone Ligasure or Harmonic electrosurgery.
Study Type
Interventional
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Women undergoing minimally invasive surgery (MIS) hysterectomy with Bilateral Salpingo Oophorectomy (BSO) for either a benign or malignant condition.
- Performance Status of 0-1
- Must have the ability to understand and willingness to sign a written informed consent document
Exclusion Criteria:
- History of radical pelvic surgery.
- History of stage IV-V uterine prolapse or hysteropexy
- History of prior ureteral injury or retroperitoneal dissection
- Known hydronephrosis.
- Known congenital genitourinary or gynaecologic anomaly
- Any known obstructing mass along any portion of the pelvic ureter
- Known American Society for Reproductive Medicine (ASRM) stage III/IV endometriosis (obliteration of the cul-de-sac)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Cook Bush DL™ Ureteral Illuminating Catheter
As part of this study an additional tool will be used during the hysterectomy.
This tool is called a Cook Bush DL™ Ureteral Illuminating Catheter, which is a lighted ureteral stent.
This is a very thin tube that goes into the ureter.
A urologist, who is an expert at placing these devices, will insert a stent into each ureter during surgery.
The lighted stents will help effectively find the ureters and keep track of them during the surgery.
This same procedure is already being done in many other forms of abdominal surgery to help find the ureter.
The stents will be removed before the surgery is complete and treatment will not differ in any other way.
|
This is a very thin tube that goes into a ureter to more effectively find and track the ureter during surgeries
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Distance from the ureter to the uterine vessels
Time Frame: Cross-sectional measurement at time of surgery
|
To determine the shortest distance from the ureter to the uterine vessels to show the variation of ureteral position to the uterine and gonadal vessels during total laparoscopic hysterectomy prior to and following opening the retroperitoneum.
Lighted ureteral stents will be placed cystoscopically.
This will be done to clearly delineate the ureter and facilitate measuring the ureter to the infundibulopelvic (IP) and ureter to uterine vessel distances.
|
Cross-sectional measurement at time of surgery
|
|
The distance from the ureter to the right gonadal vessel at the pelvic sidewall
Time Frame: Cross-sectional measurement at time of surgery
|
To determine the average distance from the ureter to the right gonadal vessel in infundibulo-pelvic (IP) at the pelvic sidewall.
This is to show the variation of ureteral position to the uterine and gonadal vessels during total laparoscopic hysterectomy prior to and following opening the retroperitoneum.
Lighted ureteral stents will be placed cystoscopically.
This will be done to clearly delineate the ureter and facilitate measuring the ureter to the infundibulopelvic (IP) and ureter to uterine vessel distances.
|
Cross-sectional measurement at time of surgery
|
|
The distance from the ureter to the left gonadal vessel at the pelvic sidewall
Time Frame: Cross-sectional measurement at time of surgery
|
To determine the distance from the ureter to the left gonadal vessel in infundibulo-pelvic (IP) at the pelvic sidewall.
This is to show the variation of ureteral position to the uterine and gonadal vessels during total laparoscopic hysterectomy prior to and following opening the retroperitoneum.
Lighted ureteral stents will be placed cystoscopically.
This will be done to clearly delineate the ureter and facilitate measuring the ureter to the infundibulopelvic (IP) and ureter to uterine vessel distances.
|
Cross-sectional measurement at time of surgery
|
|
The distance from the ureter to the right gonadal vessel where the gonadal vessel enter in to the ovary
Time Frame: Cross-sectional measurement at time of surgery
|
To determine the distance from the ureter to the right gonadal vessel in the infundibulo-pelvic (IP) ligament at the point where the gonadal vessels enter in to the ovary.
This is to show the variation of ureteral position to the uterine and gonadal vessels during total laparoscopic hysterectomy prior to and following opening the retroperitoneum.
Lighted ureteral stents will be placed cystoscopically.
This will be done to clearly delineate the ureter and facilitate measuring the ureter to the infundibulopelvic (IP) and ureter to uterine vessel distances.
|
Cross-sectional measurement at time of surgery
|
|
The distance from the ureter to the left gonadal vessel where the gonadal vessel enter in to the ovary
Time Frame: Cross-sectional measurement at time of surgery
|
To determine the distance from the ureter to the left gonadal vessel in the infundibulo-pelvic (IP) ligament at the point where the gonadal vessels enter in to the ovary.
This is to show the variation of ureteral position to the uterine and gonadal vessels during total laparoscopic hysterectomy prior to and following opening the retroperitoneum.
Lighted ureteral stents will be placed cystoscopically.
This will be done to clearly delineate the ureter and facilitate measuring the ureter to the infundibulopelvic (IP) and ureter to uterine vessel distances.
|
Cross-sectional measurement at time of surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
To determine the burst pressure of infundibulopelvic (IP) ligament which had Ligasure electrosurgery
Time Frame: Cross-sectional measurement at time of surgery
|
To determine the burst pressure of segments of IP ligament that have undergone Ligasure electrosurgery.
The Ligasure electrosurgery cuts and seals the tissue during surgery.
The burst pressure gives a measure of how well the tissue is sealed.
|
Cross-sectional measurement at time of surgery
|
|
To determine the burst pressure of infundibulopelvic ligament which had Harmonic electrosurgery
Time Frame: Cross-sectional measurement at time of surgery
|
To determine the burst pressure of segments of IP ligament that have undergone Harmonic electrosurgery.
The Harmonic electrosurgery cuts and seals the tissue during surgery.
The burst pressure gives a measure of how well the tissue is sealed.
|
Cross-sectional measurement at time of surgery
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
To determine thermal spread from a Ligasure to show the
Time Frame: Cross-sectional measurement immediately after surgery
|
Thermal spread is the dispersal of heat into surrounding tissue during electrosurgeries, causing damage to the tissue.In order to measure thermal spread, the gonadal vessels will be harvested after the specimen (uterus, tubes, ovaries and cervix) has been removed from the patient
|
Cross-sectional measurement immediately after surgery
|
|
To determine thermal spread from a Harmonic device
Time Frame: Cross-sectional measurement immediately after surgery
|
Thermal spread is the dispersal of heat into surrounding tissue during electrosurgeries, causing damage to the tissue.
In order to measure thermal spread, the gonadal vessels will be harvested after the specimen (uterus, tubes, ovaries and cervix) has been removed from the patient
|
Cross-sectional measurement immediately after surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Robert Debernardo, MD, Cleveland Clinic, Case Comprehensive Cancer Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
April 1, 2018
Primary Completion (Anticipated)
December 1, 2019
Study Completion (Anticipated)
June 1, 2020
Study Registration Dates
First Submitted
April 14, 2017
First Submitted That Met QC Criteria
April 20, 2017
First Posted (Actual)
April 21, 2017
Study Record Updates
Last Update Posted (Actual)
February 27, 2018
Last Update Submitted That Met QC Criteria
February 24, 2018
Last Verified
February 1, 2018
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- CASE11815
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hysterectomy
-
Hitit UniversityErol Olcok Corum Training and Research HospitalCompletedHysterectomy (MeSH nr: E04.950.300.399) | Had Undergone a Hysterectomy | Had Not Been Diagnosed With Cancer | After HysterectomyTurkey (Türkiye)
-
Zuyderland Medisch CentrumCatharina Ziekenhuis EindhovenRecruitingHysterectomy | Natural Orifice Transluminal Endoscopic Surgery | Vaginal HysterectomyNetherlands
-
Muğla Sıtkı Koçman UniversityCompletedAbdominal Hysterectomy | Laparoscopic Hysterectomy
-
Università degli Studi di FerraraRecruiting
-
GCS Ramsay Santé pour l'Enseignement et la RechercheCompleted
-
University Hospitals Cleveland Medical CenterWithdrawn
-
Atlantic Health SystemUnknownHysterectomyUnited States
-
Brigham and Women's HospitalMassachusetts General HospitalCompletedHysterectomyUnited States
-
Cairo UniversityUnknown
-
Mayo ClinicTerminated
Clinical Trials on Ureteral Illuminating Catheter
-
Icahn School of Medicine at Mount SinaiCompleted
-
Carmel Medical CenterCompletedUreteral Calculi | Hydronephrosis | Ureteral ObstructionIsrael
-
The First Affiliated Hospital of University of...RecruitingKidney Calculi | Nephrolithotomy, PercutaneousChina
-
Academisch Medisch Centrum - Universiteit van Amsterdam...Alrijne HospitalCompletedKidney Diseases | Urologic Diseases | Kidney Calculi | Urinary Calculi | Urolithiasis | Stone Ureter | Stone, Kidney | Urinary Stone | Pyelonephritis | Hydronephrosis | Obstruction | Kidney Failure, Acute | Ureter Obstruction | Urinary Obstruction | Kidney Dysfunction | Kidney Insufficiency | Pyelonephritis Acute | Stone, Urinary and other conditionsNetherlands
-
The First Affiliated Hospital of University of...RecruitingUrinary Calculi | Percutaneous NephrolithotomyChina
-
The First Affiliated Hospital of University of...RecruitingKidney Calculi | Nephrolithotomy PercutaneousChina
-
Al-Azhar UniversityRecruitingKidney Stone | Retrograde Intrarenal Surgery | Ureteral StentEgypt
-
Mayo ClinicEnrolling by invitationUreteral Stent-Related Symptom | Retrograde Intra-renal SurgeryUnited States
-
Lawson Health Research InstituteBoston Scientific CorporationTerminatedUrinary CalculiCanada
-
The Children's Hospital of Zhejiang University...RecruitingUrolithiasis | Child, OnlyChina